This announcement is a separate document:
广济药业：北京市京师（武汉）律师事务所关于湖北广济药业股份有限公司2021年限制性股票激励计划部分限制性股票回购注销相关事项之法律意见书
Guangji Pharmaceutical: Legal opinion from Beijing Jingshi (Wuhan) Law Firm on matters relating to the cancellation of part of the restricted stock repurchase and cancellation of the 2021 restricted stock incentive plan of Hubei Guangji Pharmaceutical Co.,
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.